Cargando…
Aptameric Fluorescent Biosensors for Liver Cancer Diagnosis
Liver cancer is a prevalent global health concern with a poor 5-year survival rate upon diagnosis. Current diagnostic techniques using the combination of ultrasound, CT scans, MRI, and biopsy have the limitation of detecting detectable liver cancer when the tumor has already progressed to a certain...
Autores principales: | Park, Seonga, Cho, Euni, Chueng, Sy-Tsong Dean, Yoon, June-Sun, Lee, Taek, Lee, Jin-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296440/ https://www.ncbi.nlm.nih.gov/pubmed/37366982 http://dx.doi.org/10.3390/bios13060617 |
Ejemplares similares
-
Aptameric nanobiosensors for the diagnosis of COVID-19: An update
por: Krishnan, Saravanan, et al.
Publicado: (2022) -
A Graphene-Based Biosensing Platform Based on Regulated Release of an Aptameric DNA Biosensor
por: Mao, Yu, et al.
Publicado: (2015) -
Novel DNA Aptameric Sensors to Detect the Toxic Insecticide Fenitrothion
por: Trinh, Kien Hong, et al.
Publicado: (2021) -
Aptameric enzyme subunit for homogeneous DNA sensing
por: Ikebukuro, Kazunori, et al.
Publicado: (2007) -
Identification and characterization of aptameric inhibitors of human neutrophil elastase
por: Malicki, Stanisław, et al.
Publicado: (2023)